|Home | About | Journals | Submit | Contact Us | Français|
Cardiac resynchronization therapy (CRT) improves survival by paced pre-excitation of the lateral /posterolateral LV1. This patient with a history of anterior and anterolateral wall LV infarction (LV ejection fraction 10%, end- diastolic internal diameter 8.2 cm) improved two functional classes (NYHA IV to II) within 4 weeks of CRT. However, electrocardiographic imaging (ECGI) of ventricular electrical activation was at variance with this clinical effect (See figure). ECGI is a noninvasive modality for imaging epicardial potentials, electrograms, isochrones (activation sequences) and repolarization patterns from body surface electrocardiographic measurements2. Echocardiography in susbsequent months demonstrated progressive deterioration, with LV dilatation and diminishing ejection fraction. The patient deceased from heart failure shortly thereafter. Thus, this ECGI study had revealed lack of intended electrical effect of LV pacing, presaging CRT failure, despite symptomatic improvement. Non-invasive electrical imaging may have significant future utility for rapid assessment of pacing therapies.
In addition to the authors, Charulatha Ramanathan, PhD, Raja N. Ghanem PhD and Kyungmoo Ryu, PhD, also participated in the ECGI study.
The study was supported by NIH-NHLBI Merit Award R37-HL-033343 and Grant RO1- HL-49054 to Dr. Rudy.
Dr. Rudy chairs the scientific advisory board and holds equity in CardioInsight Technologies. He is an inventor of ECGI technology, for which Case Western Reserve University and Washington University hold patents.
Dr. Jia is an inventor of ECGI technology and is an equity holder and a paid employee of CardioInsight Technologies.
Dr. Varma is an investigator for CardioInsight Technologies.